Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Public ClinicalTrials.gov record NCT02547818. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a global Phase III, randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The protocol is designed to determine whether ALZT-OP1 combination treatment (ALZT-OP1a + ALZT-OP1b) will slow down, arrests, or reverse cognitive and functional decline, in subjects with evidence of early stage Alzheimer's disease (AD).
Study identification
- NCT ID
- NCT02547818
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 620 participants
Conditions and interventions
Conditions
Interventions
- ALZT-OP1a Drug
- ALZT-OP1b Drug
- Placebo ALZT-OP1a Other
- Placebo ALZT-OP1b Other
Drug · Other
Eligibility (public fields only)
- Age range
- 55 Years to 79 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 15, 2015 (Actual)
- Primary completion
- Nov 13, 2020 (Actual)
- Completion
- Nov 18, 2020 (Actual)
- Last update posted
- Nov 10, 2021
2015 – 2020
United States locations
- U.S. sites
- 69
- U.S. states
- 24
- U.S. cities
- 59
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cognitive Clinical Trials | Gilbert | Arizona | 85296 | — |
| Xenoscience | Phoenix | Arizona | 85004 | — |
| Cognitive Clinical Trials | Scottsdale | Arizona | 85251 | — |
| Territory Neurology & Research Institute | Tucson | Arizona | 85704 | — |
| Alliance Research Center | Laguna Hills | California | 92653 | — |
| Renew Behavioral Health | Long Beach | California | 90807 | — |
| Excell Research, Inc. | Oceanside | California | 92056 | — |
| University of California Irvine School of Medicine | Orange | California | 92868 | — |
| Asclepes Research Center | Panorama City | California | 91402 | — |
| Artemis Clinical Research | Riverside | California | 92503 | — |
| CITrials | Riverside | California | 92506 | — |
| Northern California Research | Sacramento | California | 95821 | — |
| Syrentys Clinical Research | Santa Ana | California | 92705 | — |
| Mile High Research Center | Denver | Colorado | 80218 | — |
| TOPAZ Clinical Research | Apopka | Florida | 32703 | — |
| Parkinson's Disease & Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| Bradenton Research Center | Bradenton | Florida | 34205 | — |
| Finlay Medical Research Group | Greenacres City | Florida | 33467 | — |
| Galiz Clinical Research | Hialeah | Florida | 33016 | — |
| The Neurology Research Group | Miami | Florida | 22176 | — |
| Premier Clinical Research Institute | Miami | Florida | 33122 | — |
| Finlay Medical Research Group | Miami | Florida | 33126 | — |
| Next Phase Research Alliance - Cano Health | Miami | Florida | 33144 | — |
| IMIC, Inc. | Miami | Florida | 33157 | — |
| Next Phase Research Alliance - MetroMed | Miami | Florida | 33186 | — |
| Next Phase Research Alliance | Miami | Florida | 33186 | — |
| Panax | Miami Lakes | Florida | 33014 | — |
| CNS Healthcare | Orlando | Florida | 32801 | — |
| Pines Care Research Center | Pembroke Pines | Florida | 33026 | — |
| Neurostudies, Inc. | Port Charlotte | Florida | 33952 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Axiom Clinical Research | Tampa | Florida | 33609 | — |
| Stedman Clinical Trials | Tampa | Florida | 33613 | — |
| Columbus Research & Wellness Institute | Columbus | Georgia | 31904 | — |
| Behavioral Health Care Associates | Schaumburg | Illinois | 60193 | — |
| Eastern Maine Medical Center | Bangor | Maine | 04401 | — |
| Coastal Health Care | Freeport | Maine | 04032 | — |
| Samuel and Alexia Bratton Memory Clinic | Easton | Maryland | 21601 | — |
| ActivMed Practices & Research, Inc. | Methuen | Massachusetts | 01844 | — |
| The Alzheimer's Disease Center | Quincy | Massachusetts | 02169 | — |
| Bronson Neurobehavioral Health | Paw Paw | Michigan | 49079 | — |
| Cognitive Clinical Trials | Bellevue | Nebraska | 68005 | — |
| Cognitive Clinical Trials | Omaha | Nebraska | 68007 | — |
| ActivMed Practices & Research Inc. | Portsmouth | New Hampshire | 03801 | — |
| Memory Enhancement Center of America | Eatontown | New Jersey | 07724 | — |
| AdvancedMed Research | Lawrenceville | New Jersey | 08648 | — |
| The NeuroCognitive Institute | Mount Arlington | New Jersey | 07856 | — |
| Albuquerque Neuroscience | Albuquerque | New Mexico | 87109 | — |
| Adirondack Medical Research Center | Glens Falls | New York | 12801 | — |
| Manhattan Behavioral Medicine | New York | New York | 10023 | — |
| Medical Research Network | New York | New York | 10128 | — |
| Nathan S. Kline Institute for Psychiatric Research | New York | New York | 10128 | — |
| Winifred Masterson Burke Medical Research Institute | White Plains | New York | 10605 | — |
| ANI Neurology, PLLC Alzheimer's Memory Center | Charlotte | North Carolina | 28270 | — |
| Raleigh Neurological Associates | Raleigh | North Carolina | 27607 | — |
| PMG Winston-Salem | Winston-Salem | North Carolina | 27103 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Insight Clincial Trials | Shaker Heights | Ohio | 44122 | — |
| Cutting Edge Research Group | Oklahoma City | Oklahoma | 73116 | — |
| Tulsa Clinical Research, Inc. | Tulsa | Oklahoma | 74114 | — |
| Pearl Clinical Research | Norristown | Pennsylvania | 19401 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Palmetto Health | Columbia | South Carolina | 29044 | — |
| Metrolina Neurological Associates, PA | Rock Hill | South Carolina | 29732 | — |
| CNS Healthcare | Memphis | Tennessee | 38119 | — |
| Neurology Associates of Arlington, P.A. | Mansfield | Texas | 76063 | — |
| Grayline Clinical Drug Trials | Wichita Falls | Texas | 76309 | — |
| Wasatch Clinical Research, LLC | Salt Lake City | Utah | 84107 | — |
| Kingfisher Cooperative | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02547818, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02547818 live on ClinicalTrials.gov.